VOYA Investment Management
WVE icon

VOYA Investment Management’s Wave Life Sciences WVE Stock Holding History

VOYA Investment Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Buy
72,048
+2,956
+4% +$19.6K ﹤0.01% 1909
2026
Q1 		$501K Sell
69,092
-43,783
-39% -$570K ﹤0.01% 1717
2025
Q4 		$1.92M Sell
112,875
-145,136
-56% -$1.47M ﹤0.01% 1236
2025
Q3 		$1.89M Buy
258,011
+227,167
+737% +$1.84M ﹤0.01% 1256
2025
Q2 		$200K Sell
30,844
-44,525
-59% -$294K ﹤0.01% 2327
2025
Q1 		$609K Sell
75,369
-1,791
-2% -$19.6K ﹤0.01% 1774
2024
Q4 		$954K Buy
77,160
+51,281
+198% +$684K ﹤0.01% 1617
2024
Q3 		$212K Sell
25,879
-1,001
-4% -$5.98K ﹤0.01% 2455
2024
Q2 		$134K Buy
26,880
+3,997
+17% +$22.8K ﹤0.01% 2594
2024
Q1 		$141K Sell
22,883
-1,909
-8% -$9.56K ﹤0.01% 2549
2023
Q4 		$125K Buy
24,792
+635
+3% +$3.39K ﹤0.01% 2702
2023
Q3 		$139K Hold
24,157
– – ﹤0.01% 2652
2023
Q2 		$87.9K Buy
+24,157
New +$97.6K ﹤0.01% 2825
2022
Q2 		– Sell
-84,660
Closed -$169K – 2904
2022
Q1 		$169K Buy
84,660
+29,924
+55% +$73.3K ﹤0.01% 2413
2021
Q4 		$172K Buy
54,736
+39,348
+256% +$163K ﹤0.01% 2560
2021
Q3 		$75K Hold
15,388
– – ﹤0.01% 2784
2021
Q2 		$102K Sell
15,388
-258
-2% -$1.69K ﹤0.01% 2769
2021
Q1 		$88K Buy
15,646
+2,708
+21% +$26K ﹤0.01% 2692
2020
Q4 		$102K Buy
+12,938
New +$109K ﹤0.01% 2560
2020
Q2 		– Sell
-10,814
Closed -$101K – 2639
2020
Q1 		$101K Hold
10,814
– – ﹤0.01% 2342
2019
Q4 		$87K Buy
+10,814
New +$265K ﹤0.01% 2580
2019
Q3 		– Sell
-8,689
Closed -$227K – 2576
2019
Q2 		$227K Buy
8,689
+872
+11% +$24.5K ﹤0.01% 2235
2019
Q1 		$304K Buy
7,817
+383
+5% +$15.5K ﹤0.01% 2050
2018
Q4 		$313K Buy
7,434
+561
+8% +$24.9K ﹤0.01% 1998
2018
Q3 		$344K Hold
6,873
– – ﹤0.01% 2074
2018
Q2 		$263K Buy
6,873
+1,884
+38% +$81.1K ﹤0.01% 2220
2018
Q1 		$200K Buy
+4,989
New +$210K ﹤0.01% 2317

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.58% 1-Year Est. Return

VOYA Investment Management's WVE Position: Q2 2026 in Review

VOYA Investment Management increased its Wave Life Sciences (WVE) stake by 4.3% in Q2 2026, buying an estimated $19.6K and bringing the position to 72,048 shares worth $419K. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

VOYA Investment Management first reported a position in WVE in Q1 2018 and has held it in 27 quarters since. The position peaked at $1.92M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • VOYA Investment Management held 72,048 shares of Wave Life Sciences worth $419K as of Q2 2026.
  • VOYA Investment Management bought 2,956 Wave Life Sciences shares in Q2 2026, an estimated $19.6K.
  • Wave Life Sciences made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1909 holding.
  • VOYA Investment Management first reported a position in Wave Life Sciences in Q1 2018 and has held it in 27 quarters since.
  • VOYA Investment Management's Wave Life Sciences position peaked at $1.92M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.